Showing 3 posts of 3 posts found.


Johnson & Johnson seals largest pharmaceutical merger of the year by purchasing Momenta for $6.5 billion

August 20, 2020
Business Services, Sales and Marketing Johnson and Johnson, Momenta

Johnson & Johnson is set to buy the Cambridge based Momenta Pharmaceuticals for $6.5 billion, making it the largest pharmaceutical …


Humira biosimilar proves efficacy in Phase 3 trial

November 30, 2016
Research and Development AbbVie, Amgen, FDA, Humira, M923, Momenta

US-based biotechnology firm Momenta Pharmaceuticals has announced that its biosimilar version of Abbvie’s autoimmune drug Humira (adalimumab) – currently the …

Mylan building

Mylan announces Momenta collaboration to develop six biosimilars

January 8, 2016
Manufacturing and Production, Sales and Marketing Heather Bresch, Momenta, Mylan, biosimilars

Mylan has entered an exclusive global collaboration agreement with Momenta Pharmaceuticals, to develop, manufacture and commercialise six of Momenta’s biosimilar …

Latest content